[NEU] YoY Quarter Result on 31-Jan-2013 [#Q4]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
30-Jan-2013
Financial Year
2012
Quarter
31-Jan-2013 [#Q4]
Profit Trend
QoQ- -121.92%
YoY- -121.92%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/01/14 31/01/13 31/01/12 31/01/11 31/01/10 CAGR
Revenue 61 1,506 2,047 0 0 0 1,162 -39.22%
PBT -8,409 -3,645 -7,381 -2,834 -1,298 -1,185 -1,248 38.04%
Tax 360 -4 -5 -9 -24 2 0 -
NP -8,049 -3,641 -7,374 -2,825 -1,273 -1,187 -1,248 37.02%
Tax Rate - - - - - - - -
Total Cost 8,110 5,147 9,421 2,825 1,273 1,187 2,410 22.75%
Ratio Analysis
31/12/15 31/12/14 31/01/14 31/01/13 31/01/12 31/01/11 31/01/10 CAGR
NP Margin -13,195.08 -241.77 -360.23 0.00 0.00 0.00 -107.40 125.46%
Per Share
31/12/15 31/12/14 31/01/14 31/01/13 31/01/12 31/01/11 31/01/10 CAGR
EPS -0.09 -0.05 -0.11 -0.04 -0.02 -0.03 -0.06 7.09%
EPS Diluted -0.09 -0.05 -0.11 -0.04 -0.02 -0.03 -0.06 7.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.